The Situation

Biomodal is an innovative biotechnology company operating in the genomics sector. As the business continued to scale, it faced increasing complexity across laboratory operations, scientific equipment, specialist consumables, software platforms, manufacturing partnerships and supplier management.

The organisation needed senior procurement expertise capable of supporting critical investment decisions, strengthening commercial controls and reducing supply chain risk, without creating a large in-house procurement function. A major focus was supporting the evaluation and procurement of next-generation sequencing technology, while keeping the business flexible, protecting cash flow and securing the best possible commercial outcome.

The Challenge

The proposed technology investment represented a significant financial commitment, with multiple procurement routes available, each carrying different commercial, operational and contractual implications.

Alongside this, Biomodal needed support managing a growing portfolio of specialist suppliers across scientific equipment, consumables, software, manufacturing services and operational requirements. The objective was to ensure procurement decisions supported both immediate operational needs and long-term business growth.

Our Solution

Pro Outsourcing provided embedded procurement and commercial support across strategic sourcing, supplier negotiations, contract review, risk management and procurement governance. Activities included:

• Commercial evaluation of alternative acquisition and funding models for major technology investments.
• Supplier negotiations and commercial challenge across key procurement categories.
• Contract review and risk assessment to improve commercial protection and future flexibility.
• Procurement support for laboratory operations, manufacturing partnerships, software platforms and business services.
• Supplier governance and performance management.
• Commercial advice to support business planning and investment decisions.

The Results

The engagement delivered significant commercial and operational benefits:

• Over £250,000 of identified commercial value through procurement strategy, supplier negotiation and commercial optimisation.
• More than £800,000 of upfront capital expenditure avoided through selection of the most appropriate acquisition model.
• Improved contractual protections and reduced long-term commercial risk.
• Enhanced supplier governance and commercial visibility.
• Reduced operational risk during a critical technology transition.
• Increased organisational capacity to support future growth and innovation.
• Access to senior procurement expertise without increasing permanent headcount.

The Outcome

By combining strategic procurement expertise with an understanding of the life sciences sector, Pro Outsourcing helped Biomodal strengthen the commercial foundations needed to support continued growth. The engagement enabled the business to make major investment decisions with confidence, improve supplier management, reduce commercial risk, and focus internal resources on scientific innovation and product development.